Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-007256
Filing Date
2020-03-05
Accepted
2020-03-05 18:52:19
Documents
1
Period of Report
2020-03-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3351
  Complete submission text file 0000899243-20-007256.txt   4727
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Issuer) CIK: 0001571498 (see all company filings)

EIN.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EPIZYME, INC. 400 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address
Beaulieu Joseph (Reporting) CIK: 0001766032 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35945 | Film No.: 20692115